© 2020 MJH Life Sciences and OncLive. All rights reserved.
July 24, 2020
Daniel H. Ahn, DO, an oncologist, internist, and assistant professor of medicine at Mayo Clinic, discusses current limitations of targeted therapy in the colorectal cancer.
July 23, 2020
Daniel H. Ahn, DO, discusses updated findings from the phase 3 KEYNOTE-177 trial in patients with newly diagnosed microsatellite instability–high/mismatch repair deficient metastatic colorectal cancer.
July 17, 2020
Daniel H. Ahn, DO, discusses advancing actionable alterations in colorectal cancer.
July 13, 2020
Daniel H. Ahn, DO, discusses left- versus right-sided tumors in colorectal cancer.